ArticleLung2020
High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
Chunyan Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled itcites it